Literature DB >> 30476818

Environmental and human relevant PFOS and PFOA doses alter human mesenchymal stem cell self-renewal, adipogenesis and osteogenesis.

Shuyu Liu1, Renjun Yang1, Nuoya Yin1, Yuan-Liang Wang2, Francesco Faiola3.   

Abstract

PFOS and PFOA are two of the most abundant perfluorinated compounds (PFCs) in the environment. Previous studies have reported they have a long half-life (up to five years) once they enter into the human body. Moreover, they can potentially promote the adipogenic process by activating PPARγ. However, little is known about PFOS and PFOA chronic health impacts on humans. In this study, we employed primary human mesenchymal stem cells (hMSCs) and demonstrated that PFOS and PFOA exerted acute cytotoxicity and affected adipogenesis and osteogenesis at environmental and human relevant doses. In fact, PFOS and PFOA impaired the proper expression of CD90 (a surface antigen highly enriched in undifferentiated hMSCs) and promoted adipogenesis, presumably via their interaction with PPARγ. Moreover, PFOA partly disturbed osteogenesis. Thus, our findings not only validated the health risks of PFOS and PFOA, but also revealed new potential long-term PFOS/PFOA impacts on humans.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD90; Developmental toxicity; Human mesenchymal stem cells (hMSCs); Osteogenesis; PFOS/PFOA; PPARγ

Mesh:

Substances:

Year:  2018        PMID: 30476818     DOI: 10.1016/j.ecoenv.2018.11.064

Source DB:  PubMed          Journal:  Ecotoxicol Environ Saf        ISSN: 0147-6513            Impact factor:   6.291


  7 in total

Review 1.  PFAS and Potential Adverse Effects on Bone and Adipose Tissue Through Interactions With PPARγ.

Authors:  Andrea B Kirk; Stephani Michelsen-Correa; Cliff Rosen; Clyde F Martin; Bruce Blumberg
Journal:  Endocrinology       Date:  2021-12-01       Impact factor: 5.051

2.  Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).

Authors:  Sung Kyun Park; Xin Wang; Ning Ding; Carrie A Karvonen-Gutierrez; Antonia M Calafat; William H Herman; Bhramar Mukherjee; Siobán D Harlow
Journal:  Diabetologia       Date:  2022-04-11       Impact factor: 10.460

3.  The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds.

Authors:  Juliette Legler; Daniel Zalko; Fabien Jourdan; Miriam Jacobs; Bernard Fromenty; Patrick Balaguer; William Bourguet; Vesna Munic Kos; Angel Nadal; Claire Beausoleil; Susana Cristobal; Sylvie Remy; Sibylle Ermler; Luigi Margiotta-Casaluci; Julian L Griffin; Bruce Blumberg; Christophe Chesné; Sebastian Hoffmann; Patrik L Andersson; Jorke H Kamstra
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

4.  Redesigning an Electrochemical MIP Sensor for PFOS: Practicalities and Pitfalls.

Authors:  Giulia Moro; Davide Cristofori; Fabio Bottari; Elti Cattaruzza; Karolien De Wael; Ligia Maria Moretto
Journal:  Sensors (Basel)       Date:  2019-10-13       Impact factor: 3.576

5.  Association between gestational PFAS exposure and Children's adiposity in a diverse population.

Authors:  Michael S Bloom; Sarah Commodore; Pamela L Ferguson; Brian Neelon; John L Pearce; Anna Baumer; Roger B Newman; William Grobman; Alan Tita; James Roberts; Daniel Skupski; Kristy Palomares; Michael Nageotte; Kurunthachalam Kannan; Cuilin Zhang; Ronald Wapner; John E Vena; Kelly J Hunt
Journal:  Environ Res       Date:  2021-07-31       Impact factor: 6.498

6.  Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women.

Authors:  Ning Ding; Carrie A Karvonen-Gutierrez; William H Herman; Antonia M Calafat; Bhramar Mukherjee; Sung Kyun Park
Journal:  Int J Hyg Environ Health       Date:  2021-06-02       Impact factor: 7.401

Review 7.  The Adipose Tissue at the Crosstalk Between EDCs and Cancer Development.

Authors:  Emma Bokobza; Charlotte Hinault; Victor Tiroille; Stéphan Clavel; Frédéric Bost; Nicolas Chevalier
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-20       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.